Moon H. Hur
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).
Journal: Clinical and molecular hepatology
Published: May 09, 2026
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications 2026.
Journal: Clinical and molecular hepatology
Published: March 04, 2026
Toward Precise Risk Stratification after the Functional Cure of Chronic Hepatitis B.
Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Published: February 27, 2026
Correspondence to editorial 2 on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis".
Journal: Clinical and molecular hepatology
Published: January 09, 2026
Correspondence to editorial 1 on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis".
Journal: Clinical and molecular hepatology
Published: January 09, 2026
Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial.
Journal: Cancer immunology, immunotherapy : CII
Published: November 18, 2025
Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea.
Journal: Gut and liver
Published: September 29, 2025
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia.
Journal: Hepatology international
Published: September 06, 2025
Correction: Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: August 22, 2025
Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea.
Journal: Journal of liver cancer
Published: July 22, 2025
Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.
Journal: Diagnostic and interventional imaging
Published: July 16, 2025
Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria.
Journal: Journal of liver cancer
Published: May 25, 2025
Last Updated: 09/26/2026